PREDIABETES, MODERN VIEW ON RISK FACTORS AND TYPE 2 DIABETES MELLITUS PREVENTION (BASED ON “HUMAN AND MEDICATION” CONGRESS MATERIALS)

Cover Page

Cite item

Full Text

Abstract

Prediabetes is a condition that precedes development of type 2 diabetes mellitus (DM). In this condition glycemic ranges are between normal values and type 2 DM values. The incidence of prediabetes possibly exceeds 20%. Main risk factors of prediabetes include obesity, arterial hypertension, and lipid metabolism disorders. At present screening algorithms for prediabetes in individuals with risk factors are developed. Prevention of prediabetes progression in type 2 DM includes mandatory lifestyle changes (diet focused on weight loss and physical activity) and medical therapy in some patients.

About the authors

- -

References

  1. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes - 2018. Diabetes Care 2018; 41 (Suppl. 1): S13-S27.
  2. International diabetes federation: IDF diabetes atlas. 8th edition, 2017.
  3. Standards of specialized diabetes care. Ed. by II Dedov, MV Shestakova, AY Mayorov. 19. 8th ed. 2017; 20 (1S): 1-121.
  4. Diabetes Canada Clinical Practice Guidelines Expert Committee, Ekoe JM, Goldenberg R, Katz P Screening for Diabetes in Adults. Can J Diabetes 2018; 42 (Suppl. 1): S16-S19.
  5. NICE 2017 Type 2 diabetes: prevention in people at high risk nice.org.uk/guidance/ph38.
  6. Dedov I, Shestakova M, Galstyan G et al. The prevalence of type 2 diabetes mellitus in the 20. adult population of Russia (NATION study). Diabetes Res Clin Pract 2016; 115: 90-5.
  7. Симонова Г.И., Мустафина С.В., Печенкина Е.А. Распространенность метаболического синдрома в Сибири: популяционное исследование в г. Новосибирске. Бюл. СО РАМН. 2011; 31 (5): 100-6. @@Simonova G.I., Mustafina S.V., Pechenkina E.A. Rasprostranennost' metabolicheskogo sindroma v Sibiri: populiatsionnoe issledovanie v g. Novosibirske. Biul. SO RAMN. 2011; 31 (5): 100-6 (in Russian).
  8. Tabak AG, Herder C, Rathmann W et al. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-90.
  9. Furtado de Souza C, Gross JL, Gerchman F, Piglet CB. Pre-diabetes: diagnosis, evaluation and treatment of chronic complications. Arq Bras Endocrinol Metab 2012; 56.
  10. Gerstein HC, Santaguida P Raina P et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78 (3): 305-12.
  11. Zhang X, Gregg EW, Williamson DF et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010; 33 (7): 1665-73.
  12. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
  13. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
  14. Ramachandran A, Snehalatha C, Mary S et al. The Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Dia-betologia 2006; 49: 289-97.
  15. Saito T, Watanabe M, Nishida J et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011; 171 (15): 1352-60.
  16. Glechner A, Keuchel L, Affengruber L et al. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Prim Care Diabetes 2018; 12 (5): 393-408.
  17. Galaviz KI, Weber MB, Straus A et al. Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose. Diabetes Care 2018; 41 (7): 1526-34.
  18. Li G, Zhang P, Wang J et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014; 2: 474-80.
  19. Knowler WC, Fowler SE, Hamman RF et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374:1677-86.
  20. Nathan DM, Barrett-Connor E, Crandall JP et al. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015; 3: 866-75.
  21. Hamman RF, Wing RR, Edelstein SL et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29: 2102-7.
  22. Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr 2014; 100: 278-88.
  23. Mursu J, Virtanen JK, Tuomainen T-P et al. Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2014; 99: 328-33.
  24. Chen M, Sun Q, Giovannucci E et al. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med 2014; 12: 215.
  25. Dehghan M, Mente A, Rangarajan S et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2018; 392 (10161): 2288-97.
  26. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133: 187-225.
  27. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 2014; 383: 1999-2007.
  28. Sigal RJ, Alberga AS, Goldfield GS et al. Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents: the healthy eating aerobic and resistance training in youth randomized clinical trial. JAMA Pediatr 2014; 168: 1006-14.
  29. Thorp AA, Kingwell BA, Sethi P et al. Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc 2014; 4 (6): 2053-61.
  30. Iqbal Hydrie MZ, Basit A, Shera AS, Hussain A. Effect of intervention in subjects with high risk of diabetes mellitus in pakistan. J Nutr Metab 2012; 2012: 867604.
  31. ANSM. Metformine et risque d’acidose lactique en cas d’insuffisance renale - Point d’Information. Janvier 2018. https://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Metformi-ne-et-risque-d-acidose-lactique-en-cas-d-insuffisance-renale-Point-d-Information
  32. Mulla K, Bradbury K. Metformin use and vitamin B12 deficiency. Endocrine Abstracts (2018) 59 P092.
  33. AD/PD 2017: International Conference on Alzheimer's and Parkinson's Diseases. Abstract 312.

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies